Cargando…
The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression
Tyrosine kinase signalling within cancer cells is central to the establishment of an immunosuppressive microenvironment. Although tyrosine kinase inhibitors act, in part, to augment adaptive immunity, the increased heterogeneity and functional redundancy of the tyrosine kinome is a hurdle to achievi...
Autores principales: | Ahn, Ryuhjin, Sabourin, Valérie, Bolt, Alicia M., Hébert, Steven, Totten, Stephanie, De Jay, Nicolas, Festa, Maria Carolina, Young, Yoon Kow, Im, Young Kyuen, Pawson, Tony, Koromilas, Antonis E., Muller, William J., Mann, Koren K., Kleinman, Claudia L., Ursini-Siegel, Josie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347092/ https://www.ncbi.nlm.nih.gov/pubmed/28276425 http://dx.doi.org/10.1038/ncomms14638 |
Ejemplares similares
-
STAT1 potentiates oxidative stress revealing a targetable vulnerability that increases phenformin efficacy in breast cancer
por: Totten, Stephanie P., et al.
Publicado: (2021) -
p66ShcA potentiates the cytotoxic response of triple-negative breast cancers to PARP inhibitors
por: Cañedo, Eduardo Cepeda, et al.
Publicado: (2021) -
Clinical Potential of Kinase Inhibitors in Combination with Immune Checkpoint Inhibitors for the Treatment of Solid Tumors
por: Ahn, Ryuhjin, et al.
Publicado: (2021) -
p66ShcA functions as a contextual promoter of breast cancer metastasis
por: Lewis, Kyle, et al.
Publicado: (2020) -
The tumor suppressor function of STAT1 in breast cancer
por: Koromilas, Antonis E., et al.
Publicado: (2013)